ARTeSYN Biosolutions to expand capabilities

by Paul Fanning

ARTeSYN Biosolutions, the manufacturer of single-use solutions for biopharma processing, is to significantly expand its Waterford operations by adding 50 new roles in Production, Engineering, Customer Service and Research & Development over the next three years at its facilities in the Six Cross Roads Business Park, Waterford.

The expansion of the site increases the company’s consumables and overall production capacity by an additional 2200 ft².

The expansion is supported by the Irish Government through IDA Ireland.

The company which has invested over €1M in its manufacturing & clean room facilities currently employs 24 people in Waterford. Due to the increase in demand for its components & systems by global companies in the biopharma sector, ARTeSYN Biosolutions has identified Waterford as a key site from which to supply its growing customer base.

Minister for Training, Skills, Innovation, Research and Development John Halligan TD said: “This significant investment and creation of 50 new jobs by ARTeSYN Biosolutions is great news for the company, its staff and prospective employees and is further evidence that Waterford is a great place in which to invest, work and live. The Government is fully committed to regional development and ensuring every region benefits from employment gains. Today’s announcement demonstrates, once again, that the South East is an attractive location with much to offer investors.”

Jonathan Downey, operations director of ARTeSYN’s Waterford Headquarters said “This is a great development for ARTeSYN Biosolutions and marks a significant expansion of our Waterford manufacturing operations which allows us to ensure that we can increasingly support our global biotechnology customers in the development and production of next generation therapies to treat and cure serious illnesses. Having our Global Headquarters in Waterford illustrates the confidence that companies like ours, with a global footprint, have in Ireland. Our expansion plans, although ambitious, are achievable through the support of the Irish manufacturing ecosystem and we are looking forward to the further development of our manufacturing operations at our Irish and European facilities.”

Michael Gagne, founder and CEO of ARTeSYN Biosolutions commented "As we expand our global manufacturing capabilities to ensure our increasing ability to enable abundance in medicine, we are pleased to announce the expansion of our Irish facilities. ARTeSYN Biosolutions has been committed to the establishment and development of our Waterford Headquarters and we are excited about our expansion and increasing development of our operations in Ireland and beyond over the coming months and years."

Welcoming the announcement Eileen Sharpe, divisional manager growth markets, Europe, Emerging Business & New Forms of Investment at IDA Ireland said “ARTeSYN’s expansion adds to the significant cluster of Life Science companies in Waterford and the wider South East Region. The company’s investment in its manufacturing facility and its job creation plans are a great endorsement of not only the local management and but also the availability of talent in the region.”

This material is protected by MA Business copyright
See Terms and Conditions.
One-off usage is permitted but bulk copying is not.
For multiple copies contact the sales team.

About Us

The mission of ‘MADE in Ireland’ is to reflect and promote the success story that is Ireland’s engineering sector by reporting on the manufacturing and design exploits of Irish companies and in turn to offer those companies an information resource that accurately reflects their markets.

Get In Touch